Skip to main content
. Author manuscript; available in PMC: 2021 Jan 15.
Published in final edited form as: Nature. 2020 Jul 15;585(7824):298–302. doi: 10.1038/s41586-020-2497-0

Extended data Fig. 6 |. Controls related to the disruption of nucleolar structure following Pol II inhibition.

Extended data Fig. 6 |

(a,b) The disruption of NPM phase separation following Pol II inhibition (a) coincide with time points at which the levels of IGS ncRNAs greatly increased (b; mean±s.d., n=3 biologically independent experiments). At these time points, no reductions in the levels of the snoRNA U8 or Alu RNA were observed. (c-e) Treating cells with the Pol II inhibitor flavopiridol (FP), with various drugs that disrupt nucleolar morphology through unclear mechanisms (MG132, Doxorubicin), with the LLPS/nucleolus disruptor 1,6-hexanediol, or with the global translation inhibitor (Cycloheximide) revealed that only Pol II inhibition simultaneously disrupted NPM phase separation (c) and induced IGS ncRNA levels (d,e). Shown are representative anti-NPM immunofluorescence images (c) and two different visual representations of ncRNA levels as detected by RT-qPCR (d,e); n=3 biologically independent experiments). In the scatter plot (e), each circle represents the value of one IGS site from one of the three biological replicates. Scale bars, 5 μm.